🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this pilot research study is to test whether certain compone...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2017-10-01
Trial ID
NCT03274440
High-potency cannabis use is associated with public health risks, such as c...
Status
Recruiting
Location
Centre for Addiction and Mental Health
Start Date
2025-10-01
Trial ID
NCT07105449
Treatments Being Tested
This Phase II STTR program consists of two major goals within the overarchi...
Status
Completed
Location
McLean Hospital
Start Date
2021-08-01
Trial ID
NCT05384470
Treatments Being Tested
This trial is being conducted to demonstrate the efficacy of nabiximols, co...
Status
Terminated
Location
University of Alabama at Birmingham School of Medicine
Start Date
2020-10-01
Trial ID
NCT04203498
Treatments Being Tested
Individuals utilise substances to elevate their mood. Alcohol, cannabis, ni...
Status
Completed
Location
ART centre, Sadar Hospital
Start Date
2021-04-01
Trial ID
NCT04847388
Treatments Being Tested
To investigate what the body does to single doses of Sativex (i.e. the phar...
Status
Terminated
Location
Quintiles London Drug Research Unit
Start Date
2014-02
Trial ID
NCT01975688
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of Sativex® compared ...
Status
Completed
Location
Royal Hallamshire Hospital
Start Date
2005-07
Trial ID
NCT00710424
ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, r...
Status
Recruiting
Location
Glan Clwyd Hospital
Start Date
2023-02-03
Trial ID
NCT05629702
Treatments Being Tested
The goal of this single arm Phase I feasibility study is to investigate the...
Status
Terminated
Location
Columbia University Medical Center- Department of Radiation Oncology
Start Date
2018-03-19
Trial ID
NCT03246113
Treatments Being Tested